Adimab

Adimab company information, Employees & Contact Information

Explore related pages

Related company profiles:

Adimab is the most successful antibody discovery company in the industry, with 600+ discovery campaigns and 80+ clinical programs created with more than 130 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions. We're committed to staying at the cutting edge of protein-based therapeutic discovery to enable the highest quality IgGs, multispecifics, CARs and other modalities to allow our partners to have the most successful therapeutic programs possible.

Company Details

Employees
140
Founded
-
Address
7 Lucent Drive, Lebanon,new Hampshire 03766,united States
Phone
(603) 643-7110
Email
in****@****mab.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
adimab.com
HQ
Lebanon, New Hampshire
Looking for a particular Adimab employee's phone or email?

Adimab Questions

News

Adimab Provides Update on Pipeline - Business Wire

Adimab Provides Update on Pipeline Business Wire

Adimab Provides Year-End Update on 2024 Partnership Activities - Business Wire

Adimab Provides Year-End Update on 2024 Partnership Activities Business Wire

Biophysical properties of the clinical-stage antibody landscape - PNAS

Biophysical properties of the clinical-stage antibody landscape PNAS

Adimab: Bringing timber to biotech - wsp.com

Adimab: Bringing timber to biotech wsp.com

Deamidation and isomerization liability analysis of 131 clinical-stage antibodies: mAbs: Vol 11, No 1 - Taylor & Francis Online

Deamidation and isomerization liability analysis of 131 clinical-stage antibodies: mAbs: Vol 11, No 1 Taylor & Francis Online

Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 prime-boost vaccination - medRxiv

Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 prime-boost vaccination medRxiv

A startup launches with big plans to develop antibody drugs for coronaviruses - BioPharma Dive

A startup launches with big plans to develop antibody drugs for coronaviruses BioPharma Dive

Ligand Pharma antibody spinoff plan sets up competition with AbCellera, Adimab - MedCity News

Ligand Pharma antibody spinoff plan sets up competition with AbCellera, Adimab MedCity News

Boehringer taps Adimab for antibody discovery project - Fierce Biotech

Boehringer taps Adimab for antibody discovery project Fierce Biotech

Adimab spin-off Adagio launches with $50 million to make pan-coronavirus antibody therapies - Chemical & Engineering News

Adimab spin-off Adagio launches with $50 million to make pan-coronavirus antibody therapies Chemical & Engineering News

A Biotech Firm’s New Wood-Clad Lab Building Melds into Its Rural New Hampshire Site - Architectural Record

A Biotech Firm’s New Wood-Clad Lab Building Melds into Its Rural New Hampshire Site Architectural Record

No drug for COVID: ‘the most successful failure in my life’ - Nature

No drug for COVID: ‘the most successful failure in my life’ Nature

Adimab launches four novel antibody-based technologies - The Science Advisory Board

Adimab launches four novel antibody-based technologies The Science Advisory Board

Full article: Deamidation and isomerization liability analysis of 131 clinical-stage antibodies - Taylor & Francis Online

Full article: Deamidation and isomerization liability analysis of 131 clinical-stage antibodies Taylor & Francis Online

Adimab swaps scientist for lawyer as CEO Tillman Gerngross steps down after 15 years - Fierce Biotech

Adimab swaps scientist for lawyer as CEO Tillman Gerngross steps down after 15 years Fierce Biotech

Ablexis Announces License Agreement with Adimab - Business Wire

Ablexis Announces License Agreement with Adimab Business Wire

Lilly firms up Adimab R&D alliance, bringing its Ab platform in-house - Fierce Biotech

Lilly firms up Adimab R&D alliance, bringing its Ab platform in-house Fierce Biotech

High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy: mAbs: Vol 6, No 2 - Taylor & Francis Online

High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy: mAbs: Vol 6, No 2 Taylor & Francis Online

Adimab signs bispecific antibodies deal with Japan’s Takeda - Fierce Biotech

Adimab signs bispecific antibodies deal with Japan’s Takeda Fierce Biotech

At MIT, a bitter dispute over research puts a scientist’s prestige on the line - statnews.com

At MIT, a bitter dispute over research puts a scientist’s prestige on the line statnews.com

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak - Science | AAAS

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak Science | AAAS

Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors - Science | AAAS

Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors Science | AAAS

Full article: An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies - Taylor & Francis Online

Full article: An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies Taylor & Francis Online

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody - Science | AAAS

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody Science | AAAS

Mutant Yeast Are Cranking Out Pharma's Next Superdrug - WIRED

Mutant Yeast Are Cranking Out Pharma's Next Superdrug WIRED

Adimab broadens R&D deals with Novartis, Regeneron, Takeda - Fierce Biotech

Adimab broadens R&D deals with Novartis, Regeneron, Takeda Fierce Biotech

Anderson Kicks Off Entrepreneur-In-Residence Program - Dartmouth's Tuck School of Business

Anderson Kicks Off Entrepreneur-In-Residence Program Dartmouth's Tuck School of Business

Adimab Inks Double Deals with Merck & Lilly - Genetic Engineering and Biotechnology News

Adimab Inks Double Deals with Merck & Lilly Genetic Engineering and Biotechnology News

Adimab Partners Innovent On Monoclonal Antibody Drug Research - Asian Scientist Magazine

Adimab Partners Innovent On Monoclonal Antibody Drug Research Asian Scientist Magazine

Full article: High throughput detection of antibody self-interaction by bio-layer interferometry - Taylor & Francis Online

Full article: High throughput detection of antibody self-interaction by bio-layer interferometry Taylor & Francis Online

N.H. lost $81.3 million in federal funding. Here’s where those cuts will hit. - The Boston Globe

N.H. lost $81.3 million in federal funding. Here’s where those cuts will hit. The Boston Globe

Sylvia Richards designs mass-timber building for biotech company in New Hampshire - Dezeen

Sylvia Richards designs mass-timber building for biotech company in New Hampshire Dezeen

Adimab Signs Separate Antibody Discovery Deals with Biogen Idec and Novo Nordisk - Genetic Engineering and Biotechnology News

Adimab Signs Separate Antibody Discovery Deals with Biogen Idec and Novo Nordisk Genetic Engineering and Biotechnology News

Novo Nordisk Licenses Adimab Tech Transfer Program - Contract Pharma

Novo Nordisk Licenses Adimab Tech Transfer Program Contract Pharma

Adimab grows into E round - - Global Corporate Venturing

Adimab grows into E round - Global Corporate Venturing

Top Adimab Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant